deferiprone has been researched along with Cataract in 2 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parakh, N | 1 |
| Sharma, R | 1 |
| Prakash, O | 1 |
| Mahto, D | 1 |
| Dhingra, B | 1 |
| Sharma, S | 1 |
| Chandra, J | 1 |
| Mehdizadeh, M | 1 |
| Nowroozzadeh, MH | 1 |
2 other studies available for deferiprone and Cataract
| Article | Year |
|---|---|
Neurological Complications and Cataract in a Child With Thalassemia Major Treated With Deferiprone.
Topics: beta-Thalassemia; Cataract; Cerebellar Ataxia; Child; Deferiprone; Humans; Iron Chelating Agents; Ma | 2015 |
Posterior subcapsular opacity in two patients with thalassaemia major following deferiprone consumption.
Topics: Administration, Oral; Adult; beta-Thalassemia; Cataract; Deferiprone; Humans; Iron Chelating Agents; | 2009 |